Xpand Biotechnology

Bilthoven, Netherlands Founded: 2004 • Age: 22 yrs Acquired By Kuros Biosciences
Mini-bioreactors are developed as alternatives to 2D cell culture systems.
Request Access

About Xpand Biotechnology

Xpand Biotechnology is a company based in Bilthoven (Netherlands) founded in 2004 was acquired by Kuros Biosciences in December 2016.. Xpand Biotechnology operates in a competitive market with competitors including 10X Genomics, Mission Bio, MaxCyte, SQZBiotech and Cellares, among others.

  • Headquarter Bilthoven, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2.1 M (USD), Grant

    Jun 30, 2017

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Kuros Biosciences

    (Dec 19, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Xpand Biotechnology

  • Total Funding
  • Total Rounds 7
  • Last Round Grant — $2.1M
  • First Round

    (27 Feb 2004)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2017 Amount Grant - Xpand Biotechnology Valuation

investors

Jan, 2017 Amount Grant - Xpand Biotechnology Valuation

investors

Jul, 2015 Amount Grant - Xpand Biotechnology Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Xpand Biotechnology

Xpand Biotechnology has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Kuros Biosciences, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Provider of smart solutions for bone disease management
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Xpand Biotechnology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Xpand Biotechnology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Xpand Biotechnology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Xpand Biotechnology

Xpand Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, MaxCyte, SQZBiotech and Cellares, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Instrument systems for genomic research and sequencing libraries are developed.
domain founded_year HQ Location
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
domain founded_year HQ Location
Instrument systems for cell processing and modification are provided.
domain founded_year HQ Location
Cell therapies are developed using proprietary Cell Squeeze technology.
domain founded_year HQ Location
Medical devices for cell-based therapy manufacturing are produced.
domain founded_year HQ Location
Optical tweezers instruments for single-molecule analysis are manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Xpand Biotechnology

Frequently Asked Questions about Xpand Biotechnology

When was Xpand Biotechnology founded?

Xpand Biotechnology was founded in 2004.

Where is Xpand Biotechnology located?

Xpand Biotechnology is headquartered in Bilthoven, Netherlands. It is registered at Bilthoven, Utrecht, Netherlands.

What does Xpand Biotechnology do?

Xpand Biotechnology was founded in 2004 in Bilthoven, Netherlands, within the biotechnology sector. Mini-bioreactors for cell culture are developed as substitutes for conventional 2D systems. These are utilized in regenerative medicine research, with emphasis placed on bone tissue regeneration through calcium phosphate-based materials exhibiting osteoconductive properties. Operations focus on advancing cell culture technologies for biomedical applications.

Who are the top competitors of Xpand Biotechnology?

Xpand Biotechnology's top competitors include MaxCyte, 10X Genomics and Mission Bio.

Who are Xpand Biotechnology's investors?

Xpand Biotechnology has 3 investors. Key investors include Kuros Biosciences, European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available